Effects of enamel matrix derivative on clinical and inflammatory outcomes in periodontal maintenance patients: Randomized controlled clinical trial

被引:4
|
作者
Jasa, Erica E. [1 ]
Gradoville, Jessica M. [1 ]
Christiansen, Mary M. [1 ]
Samson, Kaeli K. [2 ]
Reinhardt, Richard A. [1 ]
Payne, Jeffrey B. [1 ]
Killeen, Amy C. [1 ]
机构
[1] Univ Nebraska Med Ctr, Coll Dent, Dept Surg Specialties, Lincoln, NE USA
[2] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Biostat, Omaha, NE USA
关键词
chronic periodontitis; enamel matrix proteins; interleukin-1beta; ALVEOLAR-TYPE DEFECTS; ACCESS FLAP SURGERY; INTRABONY DEFECTS; SYSTEMIC ANTIBIOTICS; PROTEINS; EMDOGAIN(R); ATTACHMENT; ADJUNCTS;
D O I
10.1002/JPER.19-0623
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background Efficient methods to treat persistent pockets during periodontal maintenance therapy (PMT) require further investigation. The hypothesis of this randomized controlled clinical trial was that local application of enamel matrix derivative (EMD) added to papilla reflection/root preparation (PR/RP) could enhance clinical and inflammatory outcomes, primarily clinical attachment level (CAL). Methods Fifty PMT patients with generalized stage III-IV, grade B periodontitis presenting with a 6- to 9-mm interproximal PD were randomly allocated to (PR/RP+EMD; n = 24) and control (PR/RP+saline; n = 26) therapies by sex and smoking status. Roots were treated with reflection of interproximal papillae, root planing assisted with endoscope evaluation, and acid etching, followed by EMD or saline application. Probing depth (PD), CAL, plaque index (PI), and interproximal bone height were evaluated at baseline and 12-months post-therapy. Gingival crevicular fluid, bleeding on probing (BOP), and interleukin-1 beta were tested (ELISA) at baseline, 2 weeks, and 6 and 12 months. Groups were compared over time and between groups with Wilcoxon Rank Sum and t-tests. Results Both PR/RP+ EMD and PR/RP+S resulted in significant improvements in clinical outcomes (PD and CAL, BOP) from baseline to 12 months. No significant differences were found in clinical or inflammatory outcomes between the experimental and control groups. Conclusions The addition of EMD to PR/RP does not significantly improve clinical or inflammatory outcomes compared with PR/RP alone during periodontal maintenance therapy.
引用
收藏
页码:1400 / 1408
页数:9
相关论文
共 50 条
  • [21] Enamel matrix derivative as an adjunct to minimally invasive non-surgical treatment of intrabony defects: A randomized clinical trial
    Anoixiadou, Styliani
    Parashis, Andreas
    Vouros, Ioannis
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2022, 49 (02) : 134 - 143
  • [22] Hydroxyapatite/β-tricalcium phosphate and enamel matrix derivative for treatment of proximal class II furcation defects: a randomized clinical trial
    Peres, Maria F. S.
    Ribeiro, Erica D. P.
    Casarin, Renato C. V.
    Ruiz, Karina G. S.
    Junior, Francisco H. N.
    Sallum, Enilson A.
    Casati, Marcio Z.
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2013, 40 (03) : 252 - 259
  • [23] Five years clinical results following treatment of human intra-bony defects with an enamel matrix derivative: A randomized controlled trial
    Bhutda, Girish
    Deo, Vikas
    ACTA ODONTOLOGICA SCANDINAVICA, 2013, 71 (3-4) : 764 - 770
  • [24] Maxillary Sinus Floor Elevation Surgery With BioOss Mixed With Enamel Matrix Derivative: A Human Randomized Controlled Clinical and Histologic Study
    Vincent-Bugnas, Severine
    Charbit, Yves
    Charbit, Mathieu
    Dard, Michel
    Pippenger, Benjamin
    JOURNAL OF ORAL IMPLANTOLOGY, 2020, 46 (05) : 507 - 513
  • [25] The Outcomes of Enamel Matrix Derivative on Periodontal Regeneration under Diabetic Conditions
    Narita, Laura Elena
    Mester, Alexandru
    Onisor, Florin
    Bran, Simion
    Onicas, Maria Ioana
    Voina-Tonea, Andrada
    MEDICINA-LITHUANIA, 2021, 57 (10):
  • [26] Two-year randomized clinical trial of enamel matrix derivative treated infrabony defects: radiographic analysis
    Ragghianti Zangrando, Mariana Schutzer
    Chambrone, Daniela
    Pasin, Ivan Munhoz
    Conde, Marina Clemente
    Pannuti, Claudio Mendes
    Pugliesi Alves de Lima, Luiz Antonio
    BMC ORAL HEALTH, 2014, 14
  • [27] The flapless approach with and without enamel matrix derivatives for the treatment of intrabony defects: A randomized controlled clinical trial
    Aimetti, Mario
    Stasikelyte, Morta
    Mariani, Giulia Maria
    Cricenti, Luca
    Baima, Giacomo
    Romano, Federica
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2024, 51 (09) : 1112 - 1121
  • [28] Enamel matrix proteins in the regenerative therapy of deep intrabony defects - A multicentre randomized controlled clinical trial
    Tonetti, MS
    Lang, NP
    Cortellini, P
    Suvan, JE
    Adriaens, P
    Dubravec, D
    Fonzar, A
    Fourmousis, I
    Mayfield, L
    Rossi, R
    Silvestri, M
    Tiedemann, C
    Topoll, H
    Vangsted, T
    Wallkamm, B
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2002, 29 (04) : 317 - 325
  • [29] Enamel matrix derivative promotes new bone formation in xenograft assisted maxillary anterior ridge preservation-A randomized controlled clinical trial
    Mercado, Faustino
    Vaquette, Cedryck
    Hamlet, Stephen
    Ivanovski, Saso
    CLINICAL ORAL IMPLANTS RESEARCH, 2021, 32 (06) : 732 - 744
  • [30] Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years
    De Ry, Siro P.
    Roccuzzo, Andrea
    Lang, Niklaus P.
    Sculean, Anton
    Salvi, Giovanni E.
    JOURNAL OF PERIODONTOLOGY, 2022, 93 (04) : 548 - 559